Ira Gotliv

Ira Gotliv

Company: Emendo Biotherapeutics

Job title: Vice President – Preclinical Research


A Next-Generation Treatment for Familial Hypercholesterolaemia 1:30 pm

Exploring a novel CRISPR-based gene editing approach to upregulate LDLR expression Outlining the potential efficacy, safety and dosing benefits of avoiding PCSK9 knockouts Explaining the benefits of proprietary novel nucleases for this treatment optionRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.